Colmenares María, Kima Peter E, Samoff Erika, Soong Lynn, McMahon-Pratt Diane
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520-8034, USA.
Infect Immun. 2003 Jun;71(6):3172-82. doi: 10.1128/IAI.71.6.3172-3182.2003.
Previous studies have demonstrated that protection against New World leishmaniasis caused by Leishmania amazonensis can be elicited by immunization with the developmentally regulated Leishmania amastigote antigen, P-8. In this study, several independent experimental approaches were employed to investigate the protective immunological mechanisms involved. T-cell subset depletion experiments clearly indicate that elicitation of CD8(+) (as well as CD4(+)) effector responses is required for protection. Further, mice lacking beta(2)-microglobulin (and hence deficient in major histocompatibility complex class I antigen presentation) were not able to control a challenge infection after vaccination, indicating an essential protective role for CD8(+) T effector responses. Analysis of the events ongoing at the cutaneous site of infection indicated a changing cellular dynamic involved in protection. Early postinfection in protectively vaccinated mice, a predominance of CD8(+) T cells, secreting gamma interferon (IFN-gamma) and expressing perforin, was observed at the site of infection; subsequently, activated CD4(+) T cells producing IFN-gamma were primarily found. As protection correlated with the ratio of total IFN-gamma-producing cells (CD4(+) and CD8(+) T cells) to macrophages found at the site of infection, a role for IFN-gamma was evident; in addition, vaccination of IFN-gamma-deficient mice failed to provide protection. To further assess the effector mechanisms that mediate protection, mice deficient in perforin synthesis were examined. Perforin-deficient mice vaccinated with the P-8 antigen were unable to control infection. Thus, the elicitation of CD8(+) T cell effector mechanisms (perforin, IFN-gamma) are clearly required in the protective immune response against L. amazonensis infection in vaccinated mice.
先前的研究表明,用发育调控的利什曼原虫无鞭毛体抗原P-8进行免疫接种,可引发对亚马逊利什曼原虫引起的新大陆利什曼病的保护作用。在本研究中,采用了几种独立的实验方法来研究其中涉及的保护性免疫机制。T细胞亚群耗竭实验清楚地表明,诱导CD8(+)(以及CD4(+))效应反应是获得保护所必需的。此外,缺乏β2-微球蛋白(因此主要组织相容性复合体I类抗原呈递存在缺陷)的小鼠在接种疫苗后无法控制攻击感染,这表明CD8(+) T效应反应具有重要的保护作用。对感染皮肤部位正在发生的事件进行分析表明,保护过程中细胞动态在发生变化。在保护性接种疫苗的小鼠感染后早期,在感染部位观察到以分泌γ干扰素(IFN-γ)并表达穿孔素的CD8(+) T细胞为主;随后,主要发现产生IFN-γ的活化CD4(+) T细胞。由于保护作用与感染部位发现的总产生IFN-γ的细胞(CD4(+)和CD8(+) T细胞)与巨噬细胞的比例相关,IFN-γ的作用显而易见;此外,对IFN-γ缺陷小鼠进行疫苗接种未能提供保护。为了进一步评估介导保护作用的效应机制,对缺乏穿孔素合成的小鼠进行了检查。用P-8抗原接种的穿孔素缺陷小鼠无法控制感染。因此,在接种疫苗的小鼠针对亚马逊利什曼原虫感染的保护性免疫反应中,显然需要诱导CD8(+) T细胞效应机制(穿孔素、IFN-γ)。